2024
Winter semester 2024 / 2025
March 31st, 2025
Results colloquium
David Andreu Sanz, AG Kobold
RoseTTAFold binders as a powerful tool to leverage CAR T cell therapy
Journal club
Philipp Menauer, AG Kobold
Prasad et al. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy, Blood 2025
March 24th, 2025
Results colloquium
Viola Siegert, AG Buchner
Metabolic reprogramming in Richter Transformation
Journal club
Anja Hauptstein, AG Kobold
Silvia et al. CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML, Blood 2025
March 17th, 2025
Results colloquium
Sabine Oganesian, AG Theurich
Multidimensional charazteriation of the microenvironment in CTCL with a special focus on B cells
Journal club
Ziting Zhang, AG Helfrich
Stejerean-Todoran et al. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells, Neuro Oncol 2023
March 10th, 2025
Results colloquium
Giulia Rappa, AG Subklewe
In vitro stimulation of T cells to fight AML
Journal club
Andrew Sursanto, AG König Schnurr
Park et al. Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis, Science 2024
March 3rd, 2025
Results colloquium
Viola Siegert, AG Buchner
Cancelled
Journal club
Thomas Janert, AG Kobold
Porazzi et al. EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. Cancer Cell 2025
February 24th, 2025
Guest speaker
Group Leader, TUM University Hospital
APOBEC3A - Driver of chromosomal instability and metastasis in pancreatic cancer
February 17th, 2025
Results colloquium
Sara Egea- Rodriguez, AG Helfrich
RECQL4-mediated downregulation of MHC class II promotes immune evasion and reduced anti-PD-1 response in melanoma patients
Journal club
Selin Aidin, AG Baldauf
Wen et al. Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression. Nature Communications 2024
February 10th, 2025
Results colloquium
Lisa Gregor, AG Kobold
Ablation of prostaglandin E2 signaling through receptor knockouts enables CAR T cell therapy of solid tumors
Journal club
Vanessa Wittmann, AG Anz
Damasceno et al. STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program. Cell Reports 2022
February 6th, 2025
Guest speaker
Head of the Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck
Myeloid inflammation in health and cancer
January 27th, 2025
Results colloquium
Linda Hammann, AG Anz
The impact of CCR4 ligands on tissue Treg cells in islet autoimmunity
Journal club
Daria Shvets, AG Kobold
Hänggi K et al. 2024 Interleukin-1a release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity. Cancer Cell 2024
January 20th, 2025
Results colloquium
Julia Teppert, AG König Schnurr
Cell death-optimized 3p-RNAs for improved tumor immunotherapy
Journal club
Rasmus Müller, AG Kobold
Qiu et al. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell 2024
January 13th, 2025
Guest speaker
Team Leader, Biotherapies Genetics and Oncology (BioGO), University of Bordeaux
Lentivector-based targeted cancer gene therapy
January 6th, 2025
Public Holiday
December 16th, 2024
Educational colloquium
Dr. med. vet. Charlotte Marx
High- Dimensional flow cytometry in cancer research
Journal club
Helen Stirling, AG Rothenfußer
Singh et al. A Zika virus- specific lgM elicites in pregnany exhibits ultrapotent neutralization. Cell 2022
December 9th, 2024
Results colloquium
Alexandra Leutbecher, AG Subklewe
Antibody-based immunotherapy for the treatment of epithelial ovarian cancer
Journal club
Distribution of team jobs for 2025
Stefan Niedermeier, AG Buchner
Baldwin et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell 2024
December 2nd, 2024
Guest speaker
Constructing biological function with deep learning based de novo protein design
November 25th, 2024
Guest speaker
KnotBodies® - Creating ion channel modulating antibodies by fusing Knottins into antibody loops
November 18th, 2024
Results colloquium
Dr. Ngoc-Thien-Thu Nguyen, AG Kobold
Immunotherapy in a case
Journal club
Lisa Gregor, AG Kobold
Cancelled
November 11th, 2024
Results colloquium
Jan Gärtig, AG Anz
CCL22 - the root of all evil?
Journal club
Amelie Muth, AG Subklewe
Guerrero et al. GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency. Nature Communications 2024
November 4th, 2024
Results colloquium
Journal club
Mara Henrich, AG Kobold
David Andreu Sanz, AG Kobold
CAR T cell therapy in colorectal cancer
Feng et al. The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer. Nature 2024
October 28th, 2024
Results colloquium
Rasmus Müller, AG Kobold
Serotonin receptor-induced trafficking of CAR T cells into solid tumors
Journal club
Julia Teppert, AG König/ Schnurr
Chibaya et al. Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Science Translational Medicine 2024
October 21st, 2024
Results colloquium
Till Johannsmann, AG Daniel
Novel modulators of regulatory T cells to control autoimmunity vs cancer
Journal club
Alexandra Triebig, AG Kroiß
Van Elsas MJ et al. Immunotherapy-activated T cells recruit and late-stage activated M1-like macrophages that are critical for therapeutic efficacy. Cancer Cell 2024
October 14th, 2024
Results colloquium
Stefan Niedermeier, AG Buchner
Tumor microenvironment remodeling and increased ferroptosis sensitivity during Richter Transformation
Journal club
Sabine Oganesian, AG Theurich
Gaydosik et al. The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. JCI Insight 2023
October 7th, 2024
Results colloquium
Emanuele Carlini, AG Kobold
Introducing a non-canonical IL-23R signalling into CSF-1R+ CAR-T cells
Journal club
Nilofer Abdul Razak, AG König/ Schnurr
Ng et al. Deterministic reprogramming of neutrophils within tumors. Science 2024
Summer semester 2024
September 30th, 2024
Educational colloquium
Dr. Marcel Trefny, AG Kobold
GPCRs for cancer immunotherapy
September 23rd, 2024
Results colloquium
Monika Sponheimer
TNF-alpha and IFN-gamma: The good and evil in CD70-directed NK cell based-Immunotherapy for AML
Journal club
Tanja Maier, AG Kroiß
Wilmouth et al. Sexually dimorphic activation of innate antitumor immunity prevents ACC development. Science Advances 2022
July 22nd, 2024
Guest speaker
Targeted radiotherapies: An emerging therapeutic modality driving the promise of precision medicines
July 15th, 2024
Results colloquium
Charlotte Carcopino, AG Kobold
Arming iPSC-derived NK cells with a chimeric antigen receptor for the treatment of acute myeloid leukemia
Journal club
Emanuele Carlini, AG Kobold
Zhu et al. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma. Signal Transduct Target Therapy 2024
July 8th, 2024
Results colloquium
Alejandro Salinas, AG Baldauf
Optimizing delivery of the lentiviral protein Vpx to overcome chemotherapy resistance in AML
Journal club
Jan Gärtig, AG Anz
Plebanek et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Science Immunology 2024
July 1st, 2024
Results colloquium
Emre Erdogan, AG Kobold
Development of a CAR that specifically and selectively recognizes AML blasts
Journal club
Alexandra Leutbecher, AG Subklewe
Huang et al. Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nature Cancer 2024
June 24th, 2024
Guest speaker
Patenting of Biotechnology Inventions
June 17th, 2024
Results colloquium
Sandra Dirschl, AG Daniel
Restoring impaired Treg cells by targeted miRNA modulation
Journal club
Adriano Carboniero, AG Teurich
Sun et al. Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation. Journal for ImmunoTherapy of Cancer 2023
June 10th, 2024
Guest speaker
Bispecific and multifunctional antibodies - From design and selection of the right format and concept to technical development and delivery to clinic
May 27th, 2024
Results colloquium
Viola Siegert, AG Buchner
Metabolic reprogramming during the transformation of CLL to aggressive lymphoma
Journal club
Alejandro Salinas, AG Baldauf
Chen et al. An oncolytic virus–T cell chimera for cancer immunotherapy, Nature Biotechnology 2024
May 13th, 2024
Introduction, Team Jobs
Journal club
Viola Siegert, AG Buchner
Lu et al. SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells. Cell metabolism 2024
May 6th, 2024
Results colloquium
Tanja Maier, AG Kroiß
Potential immune modulating factor in adrenocortical carcinoma (ACC)
Journal club
Giulia Rappa, AG Subklewe
Wolf et al. One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical Cancer Research 2024
April 29th, 2024
Results colloquium
Alexandra Triebig, AG Kroiß
Targeting macrophages in adrenocortical carcinoma (ACC) – impact of the TME and ferroptosis
Journal club
Linda Hammann, AG Anz
Döring et al. Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis”. Nature Cardiovascular Research 2024
April 22nd, 2024
Guest speaker
Dr. Laurie Menger
Group leader, Gustave Roussy Institute, Villejuif Cedex
LET'S IMMUN
Systematic discovery of targets improving T-cell therapy using in vivo genome-wide CRISPR screens
April 15th, 2024
Results colloquium
Jingke Tu, AG Theurich
The Characteristics of Obesity-Associated NK Cells deriving from Bone Marrow Hematopoietic Stem/Progenitor Cells
Journal club
Conghui Wang, AG König / Schnurr
Cancelled
Introduction round, team jobs